1UYA - Header Asymmetric Unit

HEADER HORMONE 11-SEP-97 1UYA

TITLE THE SOLUTION STRUCTURE OF THE A-FORM OF UROGUANYLIN-16 NMR, TITLE 2 10 STRUCTURES

COMPND MOL_ID: 1; COMPND 2 MOLECULE: UROGUANYLIN-16, ISOMER A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606

KEYWDS HORMONE, GUANYLYL CYCLASE C ACTIVATION, ISOMER A, PEPTIDE KEYWDS 2 HORMONE, SOLUTION STRUCTURE, TOPOLOGICAL STEREOISOMER, KEYWDS 3 UROGUANYLIN, SIGNAL

EXPDTA SOLUTION NMR

NUMMDL 10

AUTHOR U.C.MARX,K.ADERMANN,W.-G.FORSSMANN,P.ROESCH

REVDAT 4 24-FEB-09 1UYA 1 VERSN REVDAT 3 01-APR-03 1UYA 1 JRNL REVDAT 2 18-FEB-00 1UYA 1 JRNL REVDAT 1 18-MAR-98 1UYA 0

JRNL AUTH U.C.MARX,J.KLODT,M.MEYER,H.GERLACH,P.ROSCH, JRNL AUTH 2 W.G.FORSSMANN,K.ADERMANN JRNL TITL ONE PEPTIDE, TWO TOPOLOGIES: STRUCTURE AND JRNL TITL 2 INTERCONVERSION DYNAMICS OF HUMAN UROGUANYLIN JRNL TITL 3 ISOMERS. JRNL REF J.PEPT.RES. V. 52 229 1998 JRNL REFN ISSN 1397-002X JRNL PMID 9774236

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1UYA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 284 REMARK 210 PH : 3.3 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NDEE, X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING, REMARK 210 RESTRAINED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : ENERGY, AGREEMENT WITH REMARK 210 EXPERIMENTAL DATA REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 2 58.19 -150.10 REMARK 500 1 ASN A 9 -150.87 -152.56 REMARK 500 1 THR A 13 40.57 -98.84 REMARK 500 2 ASP A 3 84.07 -63.82 REMARK 500 2 CYS A 4 175.58 -48.88 REMARK 500 2 GLU A 5 -81.53 -90.83 REMARK 500 2 LEU A 6 66.14 -113.35 REMARK 500 2 VAL A 10 60.39 -65.61 REMARK 500 2 ALA A 11 34.46 -157.41 REMARK 500 2 THR A 13 47.55 -84.38 REMARK 500 3 ASP A 3 -157.50 -174.96 REMARK 500 3 CYS A 4 127.44 -39.68 REMARK 500 3 ASN A 9 -140.83 -151.41 REMARK 500 3 VAL A 10 37.08 -95.15 REMARK 500 4 ASP A 2 60.12 -159.62 REMARK 500 4 LEU A 6 31.66 -98.91 REMARK 500 4 ASN A 9 138.95 178.20 REMARK 500 4 ALA A 11 55.56 -145.97 REMARK 500 4 THR A 13 43.62 -98.71 REMARK 500 4 CYS A 15 72.30 -177.58 REMARK 500 5 ASN A 9 -142.09 -146.82 REMARK 500 5 VAL A 10 47.36 -100.08 REMARK 500 5 THR A 13 33.43 -95.70 REMARK 500 6 CYS A 4 128.24 -39.04 REMARK 500 6 GLU A 5 -66.33 -99.97 REMARK 500 6 LEU A 6 65.76 -100.72 REMARK 500 6 ASN A 9 128.47 179.54 REMARK 500 6 VAL A 10 59.47 -67.16 REMARK 500 6 ALA A 11 37.65 -148.13 REMARK 500 6 THR A 13 44.89 -94.09 REMARK 500 6 CYS A 15 53.74 -140.67 REMARK 500 7 ASP A 3 75.15 -164.67 REMARK 500 7 ASN A 9 -149.99 -123.23 REMARK 500 7 THR A 13 31.95 -93.51 REMARK 500 7 CYS A 15 38.24 -149.35 REMARK 500 8 ASP A 2 71.95 179.23 REMARK 500 8 CYS A 4 164.26 -46.87 REMARK 500 8 VAL A 8 30.31 -88.10 REMARK 500 8 ASN A 9 128.74 -177.10 REMARK 500 8 VAL A 10 59.80 -66.26 REMARK 500 8 ALA A 11 30.45 -154.30 REMARK 500 8 CYS A 15 47.59 -142.28 REMARK 500 9 ASN A 9 -147.47 -119.68 REMARK 500 9 ALA A 11 32.50 -94.56 REMARK 500 9 THR A 13 32.91 -95.06 REMARK 500 10 ASP A 2 44.62 -144.12 REMARK 500 10 ASP A 3 74.70 44.41 REMARK 500 10 ASN A 9 125.65 176.94 REMARK 500 10 VAL A 10 60.18 -67.51 REMARK 500 10 CYS A 15 63.85 -162.44 REMARK 500 REMARK 500 REMARK: NULL

DBREF 1UYA A 1 16 UNP Q16661 GUC2B_HUMAN 97 112

SEQRES 1 A 16 ASN ASP ASP CYS GLU LEU CYS VAL ASN VAL ALA CYS THR SEQRES 2 A 16 GLY CYS LEU

SSBOND 1 CYS A 4 CYS A 12 1555 1555 2.02 SSBOND 2 CYS A 7 CYS A 15 1555 1555 2.02

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000